Advice
Following an abbreviated submission
Carbomer 0.25% (Liquivisc) gel is accepted for use in NHS Scotland for the symptomatic treatment of dry eye syndrome where a carbomer product is the treatment of choice. It differs in only minor respects from other carbomer products and is less expensive.
Download detailed advice26KB (PDF)
Medicine details
- Medicine name:
- Carbomer 0.25% gel (Liquivisc®)
- SMC ID:
- 191/05
- Indication:
- Dry eye syndrome
- Pharmaceutical company
- Allergan Ltd
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 08 August 2005